214 related articles for article (PubMed ID: 38717194)
21. Recent update of toxicity aspects of nanoparticulate systems for drug delivery.
Patnaik S; Gorain B; Padhi S; Choudhury H; Gabr GA; Md S; Kumar Mishra D; Kesharwani P
Eur J Pharm Biopharm; 2021 Apr; 161():100-119. PubMed ID: 33639254
[TBL] [Abstract][Full Text] [Related]
22. The present and future of nanotechnology in human health care.
Sahoo SK; Parveen S; Panda JJ
Nanomedicine; 2007 Mar; 3(1):20-31. PubMed ID: 17379166
[TBL] [Abstract][Full Text] [Related]
23. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
24. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD
Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882
[TBL] [Abstract][Full Text] [Related]
25. Nanotechnology and curcumin: a novel and promising approach in digestive cancer therapy.
Zhang Y; Li Z; Huang Y; Xu Y; Zou B
Nanomedicine (Lond); 2023 Nov; 18(27):2081-2099. PubMed ID: 38078442
[TBL] [Abstract][Full Text] [Related]
26. Bacterially mediated drug delivery and therapeutics: Strategies and advancements.
Wu L; Bao F; Li L; Yin X; Hua Z
Adv Drug Deliv Rev; 2022 Aug; 187():114363. PubMed ID: 35649449
[TBL] [Abstract][Full Text] [Related]
27. A review on advancements in the application of starch-based nanomaterials in biomedicine: Precision drug delivery and cancer therapy.
Pei J; Yan Y; Jayaraman S; Rajagopal P; Natarajan PM; Umapathy VR; Gopathy S; Roy JR; Sadagopan JC; Thalamati D; Palanisamy CP; Mironescu M
Int J Biol Macromol; 2024 Apr; 265(Pt 1):130746. PubMed ID: 38467219
[TBL] [Abstract][Full Text] [Related]
28. Innovative nano-carriers in anticancer drug delivery-a comprehensive review.
Dong P; Rakesh KP; Manukumar HM; Mohammed YHE; Karthik CS; Sumathi S; Mallu P; Qin HL
Bioorg Chem; 2019 Apr; 85():325-336. PubMed ID: 30658232
[TBL] [Abstract][Full Text] [Related]
29. Solid Lipid Nanoparticles: Applications and Prospects in Cancer Treatment.
Sivadasan D; Ramakrishnan K; Mahendran J; Ranganathan H; Karuppaiah A; Rahman H
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047172
[TBL] [Abstract][Full Text] [Related]
30. Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances.
Ghaferi M; Koohi Moftakhari Esfahani M; Raza A; Al Harthi S; Ebrahimi Shahmabadi H; Alavi SE
J Drug Target; 2021 Feb; 29(2):131-154. PubMed ID: 32815741
[TBL] [Abstract][Full Text] [Related]
31. The new era of pancreatic cancer treatment: Application of nanotechnology breaking through bottlenecks.
Luo W; Zhang T
Cancer Lett; 2024 Jul; 594():216979. PubMed ID: 38795762
[TBL] [Abstract][Full Text] [Related]
32. Green nanotechnology-based drug delivery systems for osteogenic disorders.
Medina-Cruz D; Mostafavi E; Vernet-Crua A; Cheng J; Shah V; Cholula-Diaz JL; Guisbiers G; Tao J; García-Martín JM; Webster TJ
Expert Opin Drug Deliv; 2020 Mar; 17(3):341-356. PubMed ID: 32064959
[No Abstract] [Full Text] [Related]
33. Recent Advancements in Nanocarrier-assisted Brain Delivery of Phytochemicals Against Neurological Diseases.
Mishra K; Rana R; Tripathi S; Siddiqui S; Yadav PK; Yadav PN; Chourasia MK
Neurochem Res; 2023 Oct; 48(10):2936-2968. PubMed ID: 37278860
[TBL] [Abstract][Full Text] [Related]
34. Trends in nanotechnology-based delivery systems for dermal targeting of drugs: an enticing approach to offset psoriasis.
Saleem S; Iqubal MK; Garg S; Ali J; Baboota S
Expert Opin Drug Deliv; 2020 Jun; 17(6):817-838. PubMed ID: 32315216
[TBL] [Abstract][Full Text] [Related]
35. Nanotechnology-based drug delivery systems in orthopedics.
Güven E
Jt Dis Relat Surg; 2021; 32(1):267-273. PubMed ID: 33463450
[TBL] [Abstract][Full Text] [Related]
36. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
[TBL] [Abstract][Full Text] [Related]
37. Managing Apoptosis in Lung Diseases using Nano-assisted Drug Delivery System.
Shukla MK; Dubey A; Pandey S; Singh SK; Gupta G; Prasher P; Chellappan DK; Oliver BG; Kumar D; Dua K
Curr Pharm Des; 2022; 28(39):3202-3211. PubMed ID: 35422206
[TBL] [Abstract][Full Text] [Related]
38. Recent Advances in Nanotherapeutics for Neurological Disorders.
Vashist A; Manickam P; Raymond AD; Arias AY; Kolishetti N; Vashist A; Arias E; Nair M
ACS Appl Bio Mater; 2023 Jul; 6(7):2614-2621. PubMed ID: 37368486
[TBL] [Abstract][Full Text] [Related]
39. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
[TBL] [Abstract][Full Text] [Related]
40. Organelle Targeted Drug Delivery: Key Challenges, Recent Advancements and Therapeutic Implications.
Singh D
Endocr Metab Immune Disord Drug Targets; 2024 Jan; ():. PubMed ID: 38303531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
